miR-337 can be a key negative regulator in melanoma

References

• Hong J, Zhao Y and Huang W. Blocking c-myc and stat3 by E. coli expressed and enzyme digested siRNA in mouse melanoma. Biochem Biophys Res Commun 2006; 348(2):600-5; PMID:16890193; https://doi.org/10.1016/j.bbrc.2006.07.107
   PubMed Web of Science ®Google Scholar
• Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, Gershenwald JE, Xie K, Sawaya R, Huang S. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 2006; 66:3188-96; PMID:16540670; https://doi.org/10.1158/0008-5472.CAN-05-2674
   PubMed Web of Science ®Google Scholar
• Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Zhang XD, Thompson JF, Hersey P. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007; 20:416-26; PMID:17384650; https://doi.org/10.1038/modpathol.3800750
   PubMed Web of Science ®Google Scholar
• Boudny V, Adamkova L, Souckova K, Lauerova L, Krejci E and Fait V. Defective IFNalpha/gamma-induced STAT3 protein activation in human malignant melanoma cells. Mol Med Rep 2008; 1:909-15; PMID:21479505; https://doi.org/10.3892/mmr_00000049
   PubMed Web of Science ®Google Scholar
• Greenberg E, Besser MJ, Ben-Ami E, Shapira-Frommer R, Itzhaki O, Zikich D, Levy D, Kubi A, Eyal E, Onn A, et al. A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2013; 18:502-8; PMID:23902289; https://doi.org/10.3109/1354750X.2013.816777
   PubMed Web of Science ®Google Scholar
• Giles KM, Brown RA, Epis MR, Kalinowski FC and Leedman PJ. miRNA-7-5p inhibits melanoma cell migration and invasion. Biochem Biophys Res Commun 2013; 430:706-10; PMID:23206698; https://doi.org/10.1016/j.bbrc.2012.11.086
   PubMed Web of Science ®Google Scholar
• Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K, Tavazoie SF. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 2012; 151:1068-82; PMID:23142051; https://doi.org/10.1016/j.cell.2012.10.028
   PubMed Web of Science ®Google Scholar
• Gajos-Michniewicz A, Duechler M and Czyz M. MiRNA in melanoma-derived exosomes. Cancer Lett 2014; 347:29-37; PMID:24513178; https://doi.org/10.1016/j.canlet.2014.02.004
   PubMed Web of Science ®Google Scholar
• Prasad R and Katiyar SK. Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein. Oncotarget 2014; 5:10636-49; PMID:25361006; https://doi.org/10.18632/oncotarget.2527
   PubMed Web of Science ®Google Scholar
• Hanniford D, Zhong J, Koetz L, Gaziel-Sovran A, Lackaye DJ, Shang S, Pavlick A, Shapiro R, Berman R, Darvishian F, et al. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis. Clin Cancer Res : an official journal of the American Association for Cancer Research 2015; 21:4903-12; PMID:26089374; https://doi.org/10.1158/1078-0432.CCR-14-2566
   PubMed Web of Science ®Google Scholar
• Inada T, Fukushima S, Murai M, Jinnin M, Miyashita A, Nakahara S, Yamashita J, Aoi J, Masuguchi S, Ihn H. Hair shaft miRNA-221 levels as a new tumor marker of malignant melanoma. J Dermatol 2015; 42:198-201; PMID:25492219; https://doi.org/10.1111/1346-8138.12730
   PubMed Web of Science ®Google Scholar
• Ragusa M, Barbagallo C, Statello L, Caltabiano R, Russo A, Puzzo L, Avitabile T, Longo A, Toro MD, Barbagallo D, et al. miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications. Cancer Biol Ther 2015; 16:1387-1396; PMID:25951497; https://doi.org/10.1080/15384047.2015.1046021
   PubMed Web of Science ®Google Scholar
• Dror S, Sander L, Schwartz H, Sheinboim D, Barzilai A, Dishon Y, Apcher S, Golan T, Greenberger S, Barshack I, et al. Melanoma miRNA trafficking controls tumour primary niche formation. Nat Cell Biol 2016; 18:1006-17; PMID:27548915; https://doi.org/10.1038/ncb3399
   PubMed Web of Science ®Google Scholar
• Russo A, Caltabiano R, Longo A, Avitabile T, Franco LM, Bonfiglio V, Puzzo L, Reibaldi M. Increased Levels of miRNA-146a in Serum and Histologic Samples of Patients with Uveal Melanoma. Front Pharmacol 2016; 7:424; PMID:27895580; https://doi.org/10.3389/fphar.2016.00424
   PubMed Web of Science ®Google Scholar
• Wang Y, Ou Z, Sun Y, Yeh S, Wang X, Long J, Chang C. Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals. Oncogene 2016; 36(12):1644-54; PMID:27869170; https://doi.org/10.1038/onc.2016.330
   PubMed Web of Science ®Google Scholar
• Kemper K, Krijgsman O, Cornelissen-Steijger P, Shahrabi A, Weeber F, Song JY, Kuilman T, Vis DJ, Wessels LF, Voest EE, et al. Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts. EMBO Mol Med 2015; 7:1104-18; PMID:26105199; https://doi.org/10.15252/emmm.201404914
   PubMed Web of Science ®Google Scholar
• Guo B, Hui Q, Zhang Y, Chang P and Tao K. miR-194 is a negative regulator of GEF-H1 pathway in melanoma. Oncol Rep 2016; 36:2412-20; PMID:27573550; https://doi.org/10.3892/or.2016.5020
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45; PMID:11328886; https://doi.org/10.1093/nar/29.9.e45
   PubMed Web of Science ®Google Scholar
• Yang TS, Yang XH, Wang XD, Wang YL, Zhou B and Song ZS. MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell Int 2013; 13:68; PMID:23834902; https://doi.org/10.1186/1475-2867-13-68
   PubMed Web of Science ®Google Scholar
• Momtaz S, Niaz K, Maqbool F, Abdollahi M, Rastrelli L and Nabavi SM. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma. BioFactors 2016; PMID:27896891; https://doi.org/10.1002/biof.1345
   PubMed Web of Science ®Google Scholar
• Yin D, Li Y, Guo B, Liu Z, Xu Y, Wang X, Du Y, Xu L, Meng Y, Zhao X, et al. Plasmid-Based Stat3 siRNA Delivered by Functional Graphene Oxide Suppresses Mouse Malignant Melanoma Cell Growth. Oncol Res 2016; 23:229-36; PMID:27098146; https://doi.org/10.3727/096504016X14550280421449
   PubMed Web of Science ®Google Scholar
• Jazirehi AR, Torres-Collado AX and Nazarian R. Epigenetic regulation of melanoma tumor suppressor miRNA-124a. Epigenomics 2013; 5:251-2; PMID:24303550; https://doi.org/10.2217/epi.13.23
   PubMedGoogle Scholar
• Liu J, Ma L, Li C, Zhang Z, Yang G and Zhang W. Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells. Mol Oncol 2013; 7:1043-55; PMID:24001901; https://doi.org/10.1016/j.molonc.2013.08.003
   PubMed Web of Science ®Google Scholar
• Liu Y, Cui H, Wang W, Li L, Wang Z, Yang S, Zhang X. Construction of circular miRNA sponges targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma cells. International J Biochem Cell Biol 2013; 45:2643-50; PMID:24035906; https://doi.org/10.1016/j.biocel.2013.09.003
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang J, Yang Y, Hao B, Wang R, Li Y, Wu Q. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. J Exp Clin Cancer Res: CR 2013; 32:76; PMID:24422944; https://doi.org/10.1186/1756-9966-32-76
   PubMed Web of Science ®Google Scholar
• Kim SY, Lee YH and Bae YS. MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting alpha subunit of protein kinase CKII in human colorectal cancer cells. Biochem Biophys Res Commun 2012; 429:173-9; PMID:23137536; https://doi.org/10.1016/j.bbrc.2012.10.117
   PubMed Web of Science ®Google Scholar
• Zheng L, Jiao W, Mei H, Song H, Li D, Xiang X, Chen Y, Yang F, Li H, Huang K, et al. miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14. Oncotarget 2016; 7:40314-28; PMID:27259238; https://doi.org/10.18632/oncotarget.9739
   PubMed Web of Science ®Google Scholar
• Xiang X, Mei H, Zhao X, Pu J, Li D, Qu H, Jiao W, Zhao J, Huang K, Zheng L, et al. miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14. Oncotarget 2015; 6:22452-66; PMID:26084291; https://doi.org/10.18632/oncotarget.4311
   PubMed Web of Science ®Google Scholar
• Du L, Subauste MC, DeSevo C, Zhao Z, Baker M, Borkowski R, Schageman JJ, Greer R, Yang CR, Suraokar M, et al. miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. PloS one 2012; 7:e39167; PMID:22723956; https://doi.org/10.1371/journal.pone.0039167
   PubMed Web of Science ®Google Scholar
• Hauser S, Wulfken LM, Holdenrieder S, Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, et al. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma. Cancer Epidemiol 2012; 36:391-94; PMID:22542158; https://doi.org/10.1016/j.canep.2012.04.001
   PubMed Web of Science ®Google Scholar